Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001961863-24-000106
Filing Date
2024-03-13
Accepted
2024-03-13 16:44:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2816
  Complete submission text file 0001961863-24-000106.txt   4517
Mailing Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Business Address 88 SEVENTH AVE 30TH FL NEW YORK NY 10106
Aisling Capital II LP (Reporting) CIK: 0001350778 (see all company filings)

EIN.: 000000000
Type: 144

Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Subject) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36728 | Film No.: 24746594
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)